Gallium-68 DOTATOC for Management of Neuroendocrine Tumors
Status:
No longer available
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Gallium-68 DOTATOC is a material used to find neuroendocrine tumors (NETs) using positron
emission tomography (PET scan). The material has already been shown to be better than the
currently available imaging agents. This study is designed to evaluate the clinical impact of
PET CT scanning using this agent in the evaluation and management of patients with NETs.